03/18/2026
Covetrus® is excited to announce a new relationship with Wedgewood Pharmacy to expand access to 503B compounded medications for practices!
An enhanced office-stock selection is now available through Covetrus Compounding — without changes to the familiar myCovetrus ordering experience.
Through this agreement, practices will benefit from:
✅ Improved supply continuity to help minimize treatment delays
✅ A broader product selection for in-clinic care
✅ Ongoing alignment with quality and regulatory standards
✅ A single ordering experience supported by a dedicated team
Looking for more office-stock options? Explore what’s now available: https://ow.ly/rAOo50YvuOf